Detalhe da pesquisa
1.
Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial.
Eur Urol
; 85(3): 229-238, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37778952
2.
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study.
Curr Med Res Opin
; : 1-8, 2024 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38809230